In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

Example Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Right to Try Act''.

SEC. 2. USE OF UNAPPROVED MEDICAL PRODUCTS BY PATIENTS DIAGNOSED WITH A 
              TERMINAL ILLNESS.

    (a) In General.--Notwithstanding the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 301 et seq.), the Controlled Substances Act (21 
U.S.C. 801 et seq.), and any other provision of Federal law, the 
Federal Government shall not take any action to prohibit or restrict--
            (1) the production, manufacture, distribution, prescribing, 
        or dispensing of an experimental drug, biological product, or 
        device that--
                    (A) is intended to treat a patient who has been 
                diagnosed with a terminal illness; and
                    (B) is authorized by, and in accordance with, State 
                law; and
            (2) the possession or use of an experimental drug, 
        biological product, or device--
                    (A) that is described in subparagraphs (A) and (B) 
                of paragraph (1); and
                    (B) for which the patient has received a 
                certification from the patient's treating physician in 
                accordance with subsection (b).
    (b) Physician Certification.--A certification by the patient's 
treating physician referred to in subsection (a)(2)(B) must include 
each of the following:
            (1) A certification that the physician--
                    (A) is in good standing with the physician's 
                certifying organization or board; and
                    (B) has personally examined the patient.
            (2) A certification that there is no reason to conclude the 
        experimental drug, biological product, or device poses an 
        unreasonable and significant risk of danger to the patient.
            (3) A certification that the patient has been diagnosed 
        with a terminal disease or condition and does not have any 
        treatment options that--
                    (A) are comparable to treatment using the 
                experimental drug, biological product, or device or 
                otherwise satisfactory; and
                    (B) are approved, licensed, or cleared for 
                commercial distribution under section 505, 510(k), or 
                515 of the Federal Food, Drug, and Cosmetic Act (21 
                U.S.C. 355, 360(k), 360(e)) or section 351 of the 
                Public Health Service Act (42 U.S.C. 262) and are 
                available to diagnose, monitor, or treat the patient's 
                disease or condition.
            (4) A certification that the probable risk to the patient 
        from the experimental drug, biological product, or device is 
        not greater than the probable risk from the patient's disease 
        or condition.
            (5) A certification that the physician has provided the 
        patient with a written statement and oral explanation of the 
        medical treatment to be provided using the experimental drug, 
        biological product, or device.
            (6) An acknowledgement signed by the patient (or the 
        patient's legal representative) that the physician has provided 
        the written statement and oral explanation required by 
        paragraph (5), and has disclosed the following:
                    (A) That the medical treatment using the 
                experimental drug, biological product, or device is 
                experimental or nonconventional.
                    (B) That the experimental drug, biological product, 
                or device has not been approved, licensed, or cleared 
                for commercial distribution under section 505, 510(k), 
                or 515 of the Federal Food, Drug, and Cosmetic Act (21 
                U.S.C. 355, 360(k), 360(e)) or section 351 of the 
                Public Health Service Act (42 U.S.C. 262) for any 
                indication.
                    (C) The material risks generally recognized by a 
                reasonably prudent physician of the medical treatment's 
                side effects.
                    (D) An explanation of the medical treatment, 
                including the expected frequency and duration of the 
                treatment.
    (c) No Liability or Use of Outcomes.--
            (1) No liability.--Notwithstanding any other provision of 
        law, no liability shall lie against a producer, manufacturer, 
        distributor, prescriber, dispenser, possessor, or user of an 
        experimental drug, biological product, or device for the 
        production, manufacture, distribution, prescribing, dispensing, 
        possession, or use of an experimental drug, biological product, 
        or device that is in compliance, with subsection (a).
            (2) No use of outcomes.--Notwithstanding any other 
        provision of law, the outcome of any production, manufacture, 
        distribution, prescribing, dispensing, possession, or use of an 
        experimental drug, biological product, or device that was done 
        in compliance with subsection (a) shall not be used by a 
        Federal agency reviewing the experimental drug, biological 
        product, or device to delay or otherwise adversely impact 
        review or approval of such experimental drug, biological 
        product, or device.
    (d) Rules of Construction.--Nothing in this Act shall be construed 
to--
            (1) require a manufacturer or other person to make 
        available any experimental drug, biological product, or device; 
        or
            (2) prohibit a manufacturer or other person from receiving 
        compensation or recovering costs for the production, 
        manufacture, distribution, or sale of an experiment drug, 
        biological product, or device.
    (e) Definitions.--In this section:
            (1) Biological product.--The term ``biological product'' 
        has the meaning given to such term in section 351 of the Public 
        Health Service Act (42 U.S.C. 262).
            (2) Device; drug.--The terms ``device'' and ``drug'' have 
        the meanings given to such terms in section 201 of the Federal 
        Food, Drug, and Cosmetic Act (21 U.S.C. 321).
            (3) Experimental drug, biological product, or device.--The 
        term ``experimental drug, biological product, or device'' means 
        a drug, biological product, or device that--
                    (A) has successfully completed a phase 1 clinical 
                investigation;
                    (B) remains under investigation in a clinical trial 
                approved by the Food and Drug Administration; and
                    (C) is not approved, licensed, or cleared for 
                commercial distribution under section 505, 510(k), or 
                515 of the Federal Food, Drug, and Cosmetic Act (21 
                U.S.C. 355, 360(k), 360(e)) or section 351 of the 
                Public Health Service Act (42 U.S.C. 262).
            (4) Phase 1 clinical investigation.--The term ``phase 1 
        clinical investigation'' means a phase 1 clinical 
        investigation, as described in section 312.21 of title 21, Code 
        of Federal Regulations (or any successor regulations).
            (5) Terminal illness.--The term ``terminal illness'' has 
        the meaning given to such term in the State law specified in 
        subsection (a)(1)(B).
Example Output: Right to Try Act This bill requires the federal government to allow unrestricted manufacturing, distribution, prescribing, and dispensing of experimental drugs, biological products, and medical devices that are authorized by state law and intended to treat terminally ill patients. Patients receiving these treatments must be certified by a physician as having exhausted all other treatment options and as being at greater risk from their medical condition than the treatment. The physician must explain the treatment to the patient, including that the treatment is experimental, and the patient, or the patient's legal representative, must acknowledge the explanation. A manufacturer, distributor, prescriber, dispenser, possessor, or user of such a treatment has no liability regarding the treatment. The outcome of manufacture, distribution, prescribing, dispensing, possession, or use of such a treatment may not be used by a federal agency to adversely impact review or approval of the treatment. The treatment must: (1) have successfully completed a phase 1 (initial, small scale) clinical trial; (2) remain under investigation in a clinical trial approved by the Food and Drug Administration (FDA); and (3) not be approved, licensed, or cleared for sale by the FDA.  

Example Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Armed Forces Behavioral Health 
Awareness Act''.

SEC. 2. ELIGIBILITY OF MEMBERS OF THE ARMED FORCES WHO SERVE IN 
              OPERATION IRAQI FREEDOM OR OPERATION ENDURING FREEDOM FOR 
              READJUSTMENT COUNSELING AND SERVICES THROUGH VET CENTERS.

    (a) In General.--A member of the Armed Forces, including the 
Reserve components, who is deployed in support of Operation Enduring 
Freedom or Operation Iraqi Freedom shall be eligible for readjustment 
counseling and related mental health services under section 1712A of 
title 38, United States Code, through the centers for readjustment 
counseling and related mental health services (commonly known as ``Vet 
Centers'') operated by the Secretary of Veterans Affairs under that 
section.
    (b) Eligibility.--
            (1) Regulations.--Except as provided in paragraph (2), the 
        eligibility of a member of the Armed Forces, including the 
        Reserve components, for counseling and services under 
        subsection (a) shall be subject to such regulations as the 
        Secretary of Defense and the Secretary of Veterans Affairs 
        shall jointly prescribe for purposes of this section.
            (2) Duty status.--The duty status of a member may not have 
        an effect on the eligibility of the member to receive 
        counseling and services under subsection (a).

SEC. 3. GRANTS FOR NONPROFIT ORGANIZATIONS FOR THE PROVISION OF 
              EMOTIONAL SUPPORT SERVICES TO FAMILY MEMBERS OF MEMBERS 
              OF THE ARMED FORCES.

    (a) In General.--The Secretary of Defense shall carry out a program 
to award grants to nonprofit organizations that provide emotional 
support services for family members of members of the Armed Forces, 
including the Reserve components.
    (b) Award of Grants.--
            (1) Eligibility.--To be eligible for a grant under the 
        program under this section, a nonprofit organization shall meet 
        such criteria as the Secretary shall establish for purposes of 
        the program.
            (2) Application.--A nonprofit organization seeking a grant 
        under the program shall submit to the Secretary an application 
        for the grant in such form and manner as the Secretary shall 
        specify for purposes of the program.
    (c) Grants.--
            (1) Amount.--The amount of each grant awarded to a 
        nonprofit organization under the program under this section 
        shall be such amount as the Secretary determines appropriate 
        for purposes of the program.
            (2) Duration.--The duration of each grant awarded to a 
        nonprofit organization shall be such period as the Secretary 
        determines appropriate for purposes of the program.
    (d) Use of Grant Funds.--Each nonprofit organization awarded a 
grant under the program under this section shall use amounts under the 
grant to provide emotional support services for family members of 
members of the Armed Forces, including the Reserve components, through 
certain programs as the Secretary shall specify in the grant.
    (e) Funding.--Amounts for grants under the program under this 
section shall be derived from amounts authorized to be appropriated to 
the Department of Defense for military personnel.

SEC. 4. PILOT PROGRAM TO ENHANCE AWARENESS OF POST-TRAUMATIC STRESS 
              DISORDER.

    (a) Pilot Program Required.--The Secretary of the Army shall carry 
out a pilot program to enhance awareness of post-traumatic stress 
disorder among members of the Army. The Secretary shall carry out the 
pilot program in the following locations:
            (1) Fort Huachuca, Arizona.
            (2) Fort Carson, Colorado.
            (3) Fort Leonard Wood, Missouri.
    (b) Activities.--
            (1) In general.--In carrying out the pilot program, the 
        Secretary shall implement activities that--
                    (A) for a member of the Army who will be deployed 
                in support of a contingency operation, increase the 
                understanding of--
                            (i) the neurophysiological effects of 
                        stress and trauma associated with combat, 
                        including post-traumatic stress disorder; and
                            (ii) the means of eliminating or mitigating 
                        such effects after returning from combat;
                    (B) for a member of the Army deployed in support of 
                a contingency operation, reinforce the information 
                provided under subparagraph (A);
                    (C) for a member of the Army who returns from being 
                deployed in support of a contingency operation, assist 
                the member in reintegrating into noncombat life; and
                    (D) for the family of a member of the Army covered 
                under this subsection, include training and assistance 
                (including Internet-based training and assistance) at 
                each stage of deployment in order to assist the family 
                and member in recognizing and addressing post-traumatic 
                stress disorder.
            (2) Development of activities.--In developing activities 
        under this subsection, the Secretary shall consider methods to 
        address stress and trauma used by other appropriate 
        populations, including special operations forces and elite 
        athlete communities.
    (c) Duration.--The Secretary shall carry out the pilot program for 
a period of three years.
    (d) Report.--Not later than two years after the date of the 
enactment of this Act, the Secretary shall submit to Congress a report 
assessing the pilot program, including the effectiveness of the 
activities under subsection (b).
Example Output: Armed Forces Behavioral Health Awareness Act - Makes any member of the Armed Forces who is deployed in support of Operations Iraqi Freedom or Enduring Freedom eligible for readjustment counseling and related mental health services through Vet Centers (centers for such counseling and services for veterans), regardless of the member's duty status.

Directs the Secretary of Defense to award grants to nonprofit organizations that provide emotional support services for family members of members of the Armed Forces, including members of the reserves.

Requires the Secretary of the Army to carry out a pilot program to enhance awareness of post-traumatic-stress-disorder (PTSD) among members of the Army.

Example Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Encouraging Work Act of 2003''.

SEC. 2. MODIFICATIONS TO WORK OPPORTUNITY CREDIT AND WELFARE-TO-WORK 
              CREDIT.

    (a) Credit Made Permanent.--
            (1) Subsection (c) of section 51 of the Internal Revenue 
        Code of 1986 is amended by striking paragraph (4) (relating to 
        termination).
            (2) Section 51A of such Code is amended by striking 
        subsection (f).
    (b) Eligibility of Ex-Felons Determined Without Regard to Family 
Income.--Paragraph (4) of section 51(d) of such Code is amended by 
adding ``and'' at the end of subparagraph (A), by striking ``, and'' at 
the end of subparagraph (B) and inserting a period, and by striking all 
that follows subparagraph (B).
    (c) Increase in Maximum Age for Eligibility of Food Stamp 
Recipients.--Clause (i) of section 51(d)(8)(A) of such Code is amended 
by striking ``25'' and inserting ``40''.
    (d) Increase in Maximum Age for Designated Community Residents.--
            (1) In general.--Paragraph (5) of section 51(d) of such 
        Code is amended to read as follows:
            ``(5) Designated community residents.--
                    ``(A) In general.--The term `designated community 
                resident' means any individual who is certified by the 
                designated local agency--
                            ``(i) as having attained age 18 but not age 
                        40 on the hiring date, and
                            ``(ii) as having his principal place of 
                        abode within an empowerment zone, enterprise 
                        community, or renewal community.
                    ``(B) Individual must continue to reside in zone or 
                community.--In the case of a designated community 
                resident, the term `qualified wages' shall not include 
                wages paid or incurred for services performed while the 
                individual's principal place of abode is outside an 
                empowerment zone, enterprise community, or renewal 
                community.''
            (2) Conforming amendment.--Subparagraph (D) of section 
        51(d)(1) is amended to read as follows:
                    ``(D) a designated community resident,''.
    (e) Clarification of Treatment of Individuals Under Individual Work 
Plans.--Subparagraph (B) of section 51(d)(6) of such Code (relating to 
vocational rehabilitation referral) is amended by striking ``or'' at 
the end of clause (i), by striking the period at the end of clause (ii) 
and inserting ``, or'', and by adding at the end the following new 
clause:
                            ``(iii) an individual work plan developed 
                        and implemented by an employment network 
                        pursuant to subsection (g) of section 1148 of 
                        the Social Security Act with respect to which 
                        the requirements of such subsection are met.''
    (f) Effective Date.--The amendments made by this section shall 
apply to individuals who begin work for the employer after December 31, 
2003.

SEC. 3. CONSOLIDATION OF WORK OPPORTUNITY CREDIT WITH WELFARE-TO-WORK 
              CREDIT.

    (a) In General.--Paragraph (1) of section 51(d) of the Internal 
Revenue Code of 1986 is amended by striking ``or'' at the end of 
subparagraph (G), by striking the period at the end of subparagraph (H) 
and inserting ``, or'', and by adding at the end the following new 
subparagraph:
                    ``(I) a long-term family assistance recipient.''
    (b) Long-Term Family Assistance Recipient.--Subsection (d) of 
section 51 of such Code is amended by redesignating paragraphs (10) 
through (12) as paragraphs (11) through (13), respectively, and by 
inserting after paragraph (9) the following new paragraph:
            ``(10) Long-term family assistance recipient.--The term 
        `long-term family assistance recipient' means any individual 
        who is certified by the designated local agency--
                    ``(A) as being a member of a family receiving 
                assistance under a IV-A program (as defined in 
                paragraph (2)(B)) for at least the 18-month period 
                ending on the hiring date,
                    ``(B)(i) as being a member of a family receiving 
                such assistance for 18 months beginning after August 5, 
                1997, and
                    ``(ii) as having a hiring date which is not more 
                than 2 years after the end of the earliest such 18-
                month period, or
                    ``(C)(i) as being a member of a family which ceased 
                to be eligible for such assistance by reason of any 
                limitation imposed by Federal or State law on the 
                maximum period such assistance is payable to a family, 
                and
                    ``(ii) as having a hiring date which is not more 
                than 2 years after the date of such cessation.''
    (c) Increased Credit for Employment of Long-Term Family Assistance 
Recipients.--Section 51 of such Code is amended by inserting after 
subsection (d) the following new subsection:
    ``(e) Credit for Second-Year Wages for Employment of Long-Term 
Family Assistance Recipients.--
            ``(1) In general.--With respect to the employment of a 
        long-term family assistance recipient--
                    ``(A) the amount of the work opportunity credit 
                determined under this section for the taxable year 
                shall include 50 percent of the qualified second-year 
                wages for such year, and
                    ``(B) in lieu of applying subsection (b)(3), the 
                amount of the qualified first-year wages, and the 
                amount of qualified second-year wages, which may be 
                taken into account with respect to such a recipient 
                shall not exceed $10,000 per year.
            ``(2) Qualified second-year wages.--For purposes of this 
        subsection, the term `qualified second-year wages' means 
        qualified wages--
                    ``(A) which are paid to a long-term family 
                assistance recipient, and
                    ``(B) which are attributable to service rendered 
                during the 1-year period beginning on the day after the 
                last day of the 1-year period with respect to such 
                recipient determined under subsection (b)(2).
            ``(3) Special rules for agricultural and railway labor.--If 
        such recipient is an employee to whom subparagraph (A) or (B) 
        of subsection (h)(1) applies, rules similar to the rules of 
        such subparagraphs shall apply except that--
                    ``(A) such subparagraph (A) shall be applied by 
                substituting `$10,000' for `$6,000', and
                    ``(B) such subparagraph (B) shall be applied by 
                substituting `$833.33' for `$500'.''.
    (d) Repeal of Separate Welfare-to-Work Credit.--
            (1) In general.--Section 51A of such Code is hereby 
        repealed.
            (2) Clerical amendment.--The table of sections for subpart 
        F of part IV of subchapter A of chapter 1 of such Code is 
        amended by striking the item relating to section 51A.
    (e) Effective Date.--The amendments made by this section shall 
apply to individuals who begin work for the employer after December 31, 
2003.
Example Output:
Encouraging Work Act of 2003 - Amends the Internal Revenue Code to make the work opportunity credit permanent.Modifies such credit by: (1) repealing the requirement that a "qualified ex-felon" be a member of a low-income (as specified) family; (2) increasing the maximum age for eligibility of food stamp recipients to 40 years; (3) redefining the term "vocational rehabilitation referral"; (4) adding "long-term family assistance recipients" (as defined) to the definition of "targeted groups"; and (5) increasing the maximum allowable credit for employment of long-term family assistance recipients.Repeals the separate welfare-to-work credit.